These findings not only validate IFN-γ antitumor mechanisms but also provide novel insights for developing combination immunotherapy strategies against neuroblastoma (Zeki et al., 2023[135]) (Table 1(Tab. The gene discussed is IFNG; the disease is neuroblastoma.